Yum China reports Q2 results on July 30 with options traders more constructive than usual — yet the stock is still trading at a steep discount to where analysts think it belongs.
Options positioning signals an unusually bullish lean into the print. The put/call ratio has dropped to 0.49, meaningfully below its 20-day average of 0.56 and sitting near the lower half of its 52-week range. That reading is nearly a standard deviation below the mean — more call-heavy than normal, pointing to net demand for upside exposure rather than downside protection. Short interest reinforces this relatively relaxed setup: bearish positioning is just 1.35% of the free float, down roughly 0.4% on the week, with borrow conditions that are essentially frictionless — availability runs at over 2,600%, meaning the lending pool is nowhere near stressed. Cost to borrow is a negligible 0.53%. There is no meaningful short-side pressure here.
The bull case rests on valuation and earnings trajectory. At $43.40, YUMC trades on a trailing P/E of roughly 14x and an EV/EBITDA of 8.2x — undemanding for a dominant China consumer brand. The consensus sits at a buy with a mean price target around $61, implying roughly 40% upside. The ORTEX EPS surprise factor ranks in the 63rd percentile, meaning the company has a track record of beating expectations, and EPS momentum has turned positive on both 30- and 90-day windows. The dividend score ranks in the 100th percentile. Bears, however, can point to the stock's 9.7% year-to-date decline and continued underperformance against peers — Luckin Coffee and Sands China both gained around 7-8% last week while YUMC slipped about 1% — which suggests company-specific concerns around same-store sales recovery and margin execution are not yet resolved. The analyst consensus data is approximately a month old, so recent target revisions may not be fully reflected.
One institutional data point is worth noting. BlackRock appeared in the ownership filings as a relatively new position, with over 20 million shares reported in early July — a significant stake at roughly 5.9% of shares. That level of institutional involvement adds a layer of fundamental support beneath the price, though the CFO also made a small sale at $48.80 in May, above the current price level.
The last quarterly print — Q1 in late April — produced a modest 2.3% gain on the day and held those gains into the following week. The July 30 release will test whether improving earnings momentum is finally translating into same-store sales recovery strong enough to close the gap between where the stock trades and where the Street believes it should.
See the live data behind this article on ORTEX.
Open YUMC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
